Medical technology company offering ultrasonic surgical tools and advanced wound care products to healthcare providers.
Location: United States, North Carolina, Durham
Total raised: $11.16K
Investors 2
| Date | Name | Website |
| 20.06.2023 | Valiance | valiance-a... |
| - | 1315 Capit... | 1315capita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.02.2016 | - | $11.16K | - |
Mentions in press and media 16
| Date | Title | Description |
| 23.04.2025 | Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution | New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations LONDON, April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a lea... |
| 12.03.2024 | Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results | - |
| 20.12.2021 | FDA clears Bioventus’ neXus BoneScalpel Access system | Bioventus (NSDQ:BVS) announced today that it received FDA 510(k) clearance for its neXus BoneScalpel Access handpiece. Durham, North Carolina–based Bioventus said in a news release that the neXus ultrasonic surgical aspirator system — a nex... |
| 09.11.2021 | Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance | DURHAM, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for three and nine months e... |
| 09.11.2021 | Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance | DURHAM, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for three and nine months e... |
| 09.11.2021 | Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance - Form 8-K | Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance DURHAM, NC - November 9, 2021 - Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active he... |
| 18.10.2021 | BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration | DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the... |
| 27.08.2021 | Safeguard Scientifics : Trice Medical Receives Investment and International Distribution Partnership from Bioventus, Inc. | Malvern, PA (August 26th, 2021) - Trice Medical announced today that it received a strategic investment from Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing. In conjunction with leading the Series D funding r... |
| 10.08.2021 | Bioventus : Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance (Form 8-K) | Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance DURHAM, NC - August 10, 2021 - Bioventus Inc. (Nasdaq: BVS) ('Bioventus' or 'the Company'), a global leader in innovations for active healing, today reporte... |
| 10.08.2021 | Bioventus : Q2'21 Earnings Call Slides | Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements... |
Show more